The present invention relates to non-steroidal progesterone receptor modulators of the general formula (I), a process for their preparation, the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compo…
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The invention relates to novel 11- beta -phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, of general formula (I), to a method for producing them and to pharmaceutical preparations containing these compounds. …
The 17 alpha -cyanomethylestra-4,9-diene derivative compounds are of formula I: I wherein R1 is an alkyl group having from 1 to 2 carbon atoms; R2 is an alkyl group with 1 to 10 carbon atoms, an acyl group with 1 to 10 carbon atoms or a…
The 17 alpha -cyanomethylestra-4,9-diene derivative compounds are of formula I: I wherein R1 is an alkyl group having from 1 to 2 carbon atoms; R2 is an alkyl group with 1 to 10 carbon atoms, an acyl group with 1 to 10 carbon atoms or a…
The 17 alpha -cyanomethylestra-4,9-diene derivative compounds are of formula I: I wherein R1 is an alkyl group having from 1 to 2 carbon atoms; R2 is an alkyl group with 1 to 10 carbon atoms, an acyl group with 1 to 10 carbon atoms or a…
The 17 alpha -cyanomethylestra-4,9-diene derivative compounds are of formula I: I wherein R1 is an alkyl group having from 1 to 2 carbon atoms; R2 is an alkyl group with 1 to 10 carbon atoms, an acyl group with 1 to 10 carbon atoms or a…
The 17 alpha -cyanomethylestra-4,9-diene derivative compounds are of formula I: I wherein R1 is an alkyl group having from 1 to 2 carbon atoms; R2 is an alkyl group with 1 to 10 carbon atoms, an acyl group with 1 to 10 carbon atoms or a…